JPY 1509.0
(-0.07%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 1.44 Billion | 1.15 Billion | 1.38 Billion | 1.07 Billion | 1.16 Billion | 1.01 Billion |
Net Income | 741.35 Million | 694 Million | 718 Million | 576 Million | 515 Million | 485 Million |
Depreciation & Amortization | 465.17 Million | 518.26 Million | 581.44 Million | 594.01 Million | 568.11 Million | 515.62 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -11.26 Million | -21.15 Million | -3.95 Million | 12.39 Million | 23.83 Million | 14.86 Million |
Other non-cash items | 1.17 Billion | -35.1 Million | 91.5 Million | -105.4 Million | 59.05 Million | -3.66 Million |
Investing Cash Flow | -416.18 Million | -523.34 Million | -685.53 Million | -752.42 Million | -550.79 Million | -803.28 Million |
Investments in PPE | -397.86 Million | -308.71 Million | -396.06 Million | -367.43 Million | -547.52 Million | -682.64 Million |
Acquisitions | -18.18 Million | -18.59 Million | -18.13 Million | -19.66 Million | -18.9 Million | 181.66 Million |
Investment purchases | - | -596.02 Million | -500 Million | -400 Million | -600 Million | -742.35 Million |
Sales/Maturities of investments | - | 400 Million | 200 Million | 100 Million | 620.01 Million | 440.05 Million |
Other Investing Activities | -18.31 Million | -1000.00 | 28.66 Million | -65.32 Million | -4.38 Million | -2000.00 |
Financing Cash Flow | -247.94 Million | -239.24 Million | -230.93 Million | -231.16 Million | -231.13 Million | -231.01 Million |
Debt repayment | - | - | - | - | - | - |
Dividends payments | -247.89 Million | -239.24 Million | -230.93 Million | -231.16 Million | -231.13 Million | -231.01 Million |
Common Stock Repurchased | -47 Thousand | - | - | - | - | -3000.00 |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -1000.00 | - | - | - | - | -1000.00 |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -11.26 Million | -21.15 Million | -3.95 Million | 12.39 Million | 23.83 Million | 14.86 Million |
Cash at beginning of period | 2.25 Billion | 1.86 Billion | 1.39 Billion | 1.29 Billion | 915.6 Million | 938.07 Million |
Cash at end of period | 3.03 Billion | 2.25 Billion | 1.86 Billion | 1.39 Billion | 1.29 Billion | 915.6 Million |
Capital Expenditure | -397.86 Million | -308.71 Million | -396.06 Million | -367.43 Million | -547.52 Million | -682.64 Million |
Effect of forex changes on cash | - | 166 Thousand | 237 Thousand | 992 Thousand | 261 Thousand | - |
Net cash flow / Change in cash | 779.46 Million | 393.57 Million | 470.77 Million | 94.4 Million | 384.32 Million | -22.47 Million |
Free Cash Flow | 1.04 Billion | 847.28 Million | 990.93 Million | 709.56 Million | 618.47 Million | 329.18 Million |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 119 Million | 174 Million | 741.35 Million | 190 Million | 218 Million | 159 Million |
Depreciation & Amortization | - | - | 465.17 Million | - | - | 121.11 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | -11.26 Million | - | - | - |
Other non-cash items | -119 Million | -174 Million | 1.17 Billion | -190 Million | -218 Million | -159 Million |
Investing Cash Flow | - | - | -416.18 Million | - | - | - |
Investments in PPE | - | - | -397.86 Million | - | - | - |
Acquisitions | - | - | -18.18 Million | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | -18.31 Million | - | - | - |
Financing Cash Flow | - | - | -247.94 Million | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | -247.89 Million | - | - | - |
Common Stock Repurchased | - | - | -47 Thousand | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | -1000.00 | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | -11.26 Million | - | - | - |
Cash at beginning of period | - | - | 2.25 Billion | 2.51 Billion | 2.25 Billion | 2.25 Billion |
Cash at end of period | - | - | 3.03 Billion | 2.58 Billion | 2.51 Billion | 2.25 Billion |
Capital Expenditure | - | - | -397.86 Million | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | 779.46 Million | 70.29 Million | 254.11 Million | -86 Thousand |
Free Cash Flow | - | - | 1.04 Billion | - | - | 242.22 Million |
CRL
ZEAL
603239
ICL
BRWXF
OYL